Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (111-120 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|December 1, 1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionR N Jones, A L Barry
Archives of Pathology & Laboratory Medicine|May 1, 1991
Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American PathologistsR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|November 1, 1988
Interpretative criteria for the agar diffusion susceptibility test with azithromycinA L Barry, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococciL M Deshpande, R N Jones
Journal of Clinical Microbiology|May 1, 1992
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar mediumM E Erwin, R N Jones
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
International Psychogeriatrics|January 5, 2002
Education bias in the mini-mental state examinationR N Jones, J J Gallo
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 2, 2000
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugsM T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|April 1, 2000
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesA C Gales, R N Jones
Pageof 95

Showing results (111-120 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|December 1, 1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionR N Jones, A L Barry
Archives of Pathology & Laboratory Medicine|May 1, 1991
Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American PathologistsR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|November 1, 1988
Interpretative criteria for the agar diffusion susceptibility test with azithromycinA L Barry, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococciL M Deshpande, R N Jones
Journal of Clinical Microbiology|May 1, 1992
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar mediumM E Erwin, R N Jones
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
International Psychogeriatrics|January 5, 2002
Education bias in the mini-mental state examinationR N Jones, J J Gallo
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 2, 2000
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugsM T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|April 1, 2000
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesA C Gales, R N Jones
Pageof 95